Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »CureVac and EU in advanced talks for 225 million doses of Covid-19 vaccine
Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »The quest for a cure for hangover – could this tablet be the breakthrough for drinkers?
A bartender waits for customers at the Arctice ice cream parlor in the Arctic Circle near Rovaniemi, Finland pawel kopczynski / Reuters Scientists in Finland have found what they claim to be a cure for the cat. Researchers have published a study showing that alcohol-induced nausea, headaches, stress and anxiety …
Read More »For Covid-19 vaccine, J&J plans 60,000 subject pivotal trial
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »Potential Gilead blockbusters rejected by FDA. Why that’s the ‘Near-Worst-Case Scenario’ for Gilead Stock.
Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »